Aclarion (Nasdaq: ACON) Expands AI-Driven Spine Diagnostics with Scripps Health Partnership
BROOMFIELD, Colo., March 03, 2025 (GLOBE NEWSWIRE) –
Aclarion, Inc. (Nasdaq: ACON, ACONW), a pioneering healthcare technology company, has announced a commercial agreement with Scripps Health in San Diego, CA. This partnership integrates Aclarion’s Nociscan technology into the largest healthcare system in the region, granting Scripps Green and Scripps Health spine physicians access to advanced diagnostic tools for patients suffering from chronic low back pain (cLBP).
Enhancing Patient Care with Advanced Diagnostics
Each year, Scripps Health evaluates an increasing number of patients struggling with chronic low back pain. Dr. Robert Eastlack, an esteemed orthopedic surgeon at Scripps Health, highlighted the impact of this new collaboration:
“I have a strong interest in advanced diagnostics and clinical decision support tools like Nociscan. Over the past few years, I have referred numerous patients to Beverly Hills for Nociscan testing, and the additional insights it provides have proven invaluable. Now, with Nociscan available at Scripps Green, more of my colleagues and patients will benefit from this groundbreaking technology.”
About Scripps Health
- Nonprofit healthcare system with five hospitals and 19 outpatient facilities.
- Serves over half a million patients annually.
- Supported by 2,600 affiliated physicians.
- Recognized for clinical research and medical education contributions.
This partnership aligns with Scripps Health’s mission to provide cutting-edge medical advancements and improve patient care.
A Breakthrough in Chronic Low Back Pain Diagnostics
Aclarion’s Nociscan is the first evidence-supported SaaS platform designed to noninvasively differentiate between painful and nonpainful discs in the lumbar spine. By objectively quantifying chemical biomarkers linked to disc pain, Nociscan enhances diagnostic accuracy, leading to:
- More precise identification of cLBP sources.
- Better-informed treatment decisions.
- Improved patient outcomes.
Ryan Bond, Chief Strategy Officer at Aclarion, on the Partnership:
“Dr. Eastlack is a leader in spine research, contributing to over 100 peer-reviewed articles and numerous textbooks. By integrating Nociscan into Scripps Health, we are providing millions of people throughout Southern California with access to cutting-edge spine care solutions.”
Addressing a Global Health Crisis
Chronic low back pain is a significant healthcare challenge, affecting approximately 266 million individuals worldwide due to degenerative spine disease. The integration of Nociscan at Scripps Health marks a crucial step toward:
- Advancing diagnostics for cLBP.
- Enhancing treatment accuracy.
- Revolutionizing spine care through AI-driven solutions.
With this latest expansion, Aclarion continues to lead the charge in transforming spine diagnostics with AI-driven insights, empowering physicians to deliver superior patient outcomes and drive innovation in spine care research.
